← Biofrontera Inc. BFRI
Market Price
$1.31
Market Cap
$16.13M
P/E Ratio
N/A
Revenue (FY 2025)
↑11.7% YoY
$41.70M
3-Yr CAGR: 13.3%
Net Income
↑40.7% YoY
-$10.54M
Net Margin: -25.3%
Free Cash Flow
↓-30.0% YoY
-$13.36M
FCF Yield: -82.83%
EPS (Diluted)
↑67.7% YoY
$-1.04
Basic: $-1.04
Return on Equity
Efficiency
-100.5%
ROA: -36.9%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (BFRI)
All monetary values in millions ($M)
⚠️ YoY Data Quality Alert
- FY 2021: Revenue YoY (+27.9%) is identical to Gross Profit YoY (+27.9%). Verify the underlying Revenue and Gross Profit values for FY 2021 and FY 2020.
| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2020 | $18.8M | — | $10.8M | $-11.0M | — | — | — | $-12.4M | — | — |
| FY 2021 | $24.1M | +27.9% | $13.9M | $-37.7M | -243.3% | — | — | $-26.7M | $-26.7M | — |
| FY 2022 | $28.7M | +19.0% | $13.5M | $-0.6M | +98.3% | — | — | $-16.2M | $-16.2M | +39.2% |
| FY 2023 | $34.1M | +18.8% | $16.6M | $-20.1M | -3,045.5% | $-13.02 | — | $-24.9M | $-24.9M | -53.4% |
| FY 2024 | $37.3M | +9.5% | $18.7M | $-17.8M | +11.8% | $-3.22 | +75.3% | $-10.3M | $-10.3M | +58.7% |
| FY 2025 | $41.7M | +11.7% | $30.7M | $-10.5M | +40.7% | $-1.04 | +67.7% | $-13.4M | $-13.4M | -30.0% |
Valuation
Market Price
$1.31
Market Cap
$16.13M
Enterprise Value
$20.49M
P/E Ratio
N/A
P/B Ratio
1.61
FCF Yield
-82.83%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
73.71%
Operating Margin
-27.21%
Net Margin
-25.26%
Return on Equity (ROE)
-100.53%
Return on Assets (ROA)
-36.89%
Asset Turnover
1.46x
Revenue 3-Yr CAGR
13.30%
Financial Health & Liquidity
Current Ratio
0.19
Cash Ratio
0.54
Debt / Equity
1.026
Debt / Assets
0.376
Cash & Equivalents
$6.39M
Total Debt
$10.75M
Book Value / Share
$0.82
Cash Flow Efficiency
Operating Cash Flow
-$13.36M
Capital Expenditures (CapEx)
$2.00K
Free Cash Flow
-$13.36M
OCF / Revenue
-32.04%
FCF / Revenue
-32.04%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$-1.04
EPS (Basic)
$-1.04
Dividends / Share
N/A
Book Value / Share
$0.82
EPS YoY Growth
67.70%
Balance Sheet (FY 2025)
Total Assets
$28.56M
Total Liabilities
$28.56M
Stockholders' Equity
$10.48M
Current Assets
$2.28M
Current Liabilities
$11.89M